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Structural and Thermodynamic Dissection of Linear
Motif Recognition by the E. coli Sliding Clamp
Zhou Yin,† Michael J. Kelso,† Jennifer L. Beck† and Aaron J. Oakley *, †
†

School of Chemistry, University of Wollongong, Northfields Ave, Wollongong 2522, NSW, Australia

ABSTRACT: Protein-protein interactions based on linear motif (LM) recognition play roles in many
cell regulatory processes. The E. coli sliding clamp is a protein mediator of replisome formation, which
uses a common surface pocket composed of two sub-sites (I and II) to interact with LMs in multiple
binding partners. A structural and thermodynamic dissection of sliding clamp-LM recognition has been
performed, providing support for a sequential binding model. According to the model a hydrophobic Cterminal LM dipeptide sub-motif acts as an anchor to establish initial contacts within subsite I and this
is followed by formation of a stabilizing hydrogen-bonding network between the flanking LM residues
and subsite II. Differential solvation/desolvation during positioning of the sub-motifs is proposed as a
driver for the sequential binding. Our model provides general insights into linear motif recognition and
should guide the design of small-molecule inhibitors of the E. coli sliding clamp, an emerging
antibacterial target.
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INTRODUCTION
Protein-protein interaction sites govern numerous biological processes and are a well-known class of
drug targets.1 Linear motifs (LMs) are short (4-10 residues) intrinsically disordered sequences that are
often found at the termini of proteins and sometimes in loop regions.2-4 Recognition of LMs5, 6 by rigid
protein domains represents a distinct category of protein-protein interaction, with many examples
involved in cell signaling, DNA replication and other cell-regulatory processes.7-9 Recognition of LMs
by their partner proteins often shows both specific and promiscuous characteristics.10 Promiscuity
arises because the protein acts as a binding “hub” capable of interacting with multiple partners bearing
distinct (but related) LMs.10,

11

Specificity arises from the interaction of conserved LM “anchor”

residues12-14 with target receptor “hot spots”,15, 16 which when removed lead to loss of binding affinity.
In general, LM recognition events are transient and show only weak affinity (1–100 µM)17 and it has
been proposed that this may arise from the configurational entropy loss that occurs when LMs adopt
the bound conformation.18 This is supported by the fact that most LM peptides do not induce
conformational changes in their binding partners.16 Hydrophobic residues commonly found in LMs are
also thought to contribute entropically favorable desolvation free energy to the binding.3,

19, 20

A

sequential model of LM-binding via partially bound states has been proposed and is consistent with the
typically observed fast on-and-off binding kinetics.12, 13, 21
While there is growing interest in the design of drugs targeting LM-recognition sites22, 23 these efforts
are being hampered by a lack of further mechanistic insights into the binding process. Additional
structural evidence in support of the sequential binding model is required along with further evidence
connecting LM characteristics with their dynamic behavior.
The E. coli sliding clamp (SC), also known as the DNA polymerase III β subunit and the β-clamp, is
a protein-protein interaction hub that plays a central role in the bacterial DNA replication and repair
2
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machinery. It is distinctly different from and shares only topological similarity with its eukaryotic
counterpart, the proliferating cell nuclear antigen (PCNA).24, 25 The SC is a torus-shaped dimer that
surrounds double-stranded DNA functioning to recruit various binding partners to DNA.25 A single
binding pocket on each clamp monomer interacts with LMs in the various partners.26-28 The diverse
range of proteins that interact with the SC makes it one of the most trafficked elements in the cell
protein network.28 Interacting proteins include the δ-clamp loading subunit of DNA Pol III, DNA pol I,
II, IV, VI and MutS.29, 30 The central role played by the SC in multiple essential functions in bacteria
and its structural divergence from PCNA make it an attractive antibacterial target.
The LMs of SC binding partners are usually found at their N/C-termini and these isolated peptides
tend to bind to the SC with affinities similar to their parent proteins.31, 32 Conversely, when LMs are
removed the truncated proteins lose all binding affinity.33 Previous studies have shown that the
consensus motif (QLx1Lx2F/L: S/D preferred at x1, x2 may be absent) binds to a specific pocket on the
SC monomer comprised of two subsites, I and II.34, 35 A pentapeptide derived from the consensus motif,
Ac0Q1L2D3L4F5 (subscripts denoting position), binds to the SC with equivalent affinity to SC-binding
proteins (Kd ~ 1 µM ) and is considered the minimal binding motif.31, 36
In the current study, a combination of biochemical/biophysical assays and structural and theoretical
approaches have been used to unravel key mechanistic insights into E. coli SC-LM recognition. Singleresidue substitutions of the Ac0Q1L2D3L4F5 consensus peptide were used to characterize the binding
determinants and to elucidate the structural basis for the specificity of LM-binding. The weak and
transient nature typical of LM recognition was computationally probed with supporting evidence
provided from calorimetric data. The study has led us to propose a sequential binding model wherein
the anchor residues of the LM establishes initial contacts with subsite I, followed by binding of the
flanking residues to subsite II. The model is supported by steered molecular dynamics (SMD)
simulations and crystal structures, which provide snapshots into the sequential binding pathway. The
3
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desolvation/resolvation profile of almost-buried polar atoms (ABPA)37 is shown to account for the
priority of anchor-residue positioning over positioning of other residues in the LM.
RESULTS AND DISCUSSION
Interactions of Q1 with subsite II and L4F5 with subsite I. The published X-ray crystal structure of
the consensus pentapeptide Ac0Q1L2D3L4F5 in complex with the E. coli SC (PDB entry3Q4J)36 is
shown in Figure 1A. In this structure the N-terminal Ac0Q1L2 dipeptide sub-motif occupies subsite II
making three H-bonds to the backbone amides of M362, P363 and R365, and one H-bond to a bridging
water molecule (W0). The side-chain of L2 is involved in hydrophobic interactions with P363. The nonpolar C-terminal L4F5 dipeptide sub-motif occupies subsite I and makes interactions with the
hydrophobic side-chains of L177, V247, V360 and M362. In the current work, X-ray crystal structures
of the SC were obtained in complex with all five possible alanine mutants of the consensus peptide;
AcA1L2D3L4F5, AcQ1A2D3L4F5, AcQ1L2A3L4F5, AcQ1L2D3A4F5 and AcQ1L2D3L4A5 (Complexes are
denoted SCAcALDLF, SCAcQADLF, SCAcQLALF, SCAcQLDAF and SCAcQLDLA; Figure 1B–F. Crystallographic
data are provided in Table S1). The individual structures are discussed below in the context of their SC
binding affinities.

4

Page 5 of 30

A

B

C

D

E

F

A

A

Figure 1. Crystal structures of the E. coli SC bound toAc0Q1L2D3L4F5 consensus peptide (SCAcQLDLF, A)36and its alanine
mutants: SCAcALDLF (B), SCAcQADLF (C), SCAcQLALF (D), SCAcQLDAF(E) and SCAcQLDLA (F).The complexes are shown with the
SC carbon atoms shaded white and with the peptide carbon atoms colored grey (all other atoms in CPK colors).
Electrostatic potential surfaces of the binding-site are shown with blue = positive and red = negative. Dashed lines in red
represent H-bonds. A bridging water molecule (W0) is shown as a red sphere. Electron density maps (mFo–DFc) contoured
at 3σ are shown in green wire-basket form.
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The binding contribution of each residue in Ac0Q1L2D3L4F5 was probed using a series of mutant
peptides (Table 1). Alanine mutants were used to assess relative side chain contributions, and glycine
mutants were used to show the impact of backbone flexibility on affinity by way of comparison with
the alanine mutants. Other mutations were to residues with similar polarity, functional groups and/or
shape so as to differentiate the importance of each of these aspects to peptide binding. Binding
affinities for the mutants were measured using a fluorescence polarization (FP) assay employing a
fluorescently labeled tracer peptide (Kd = 70 nM, determined with binding-saturation curve fitting).
Inhibition of tracer binding to the SC was plotted against peptide concentrations and their IC50 values
calculated and transformed into Kd using the Kenakin correction for ligand depletion (Table 1).38

6
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Table 1. Effects of single-residue mutations on LM consensus peptide binding to the SC.
IC50(µM)

AcQLDLF

1.9

0.9

–8.3

0.00

QLDLF

63.2

29.5

–6.2

2.10

AcELDLF

222.1

103.6

–5.5

2.85

AcNLDLF

43.6

20.3

–6.4

1.88

AcALDLF

602.6

281.2

–4.9

3.44

AcGLDLF

976.5

455.7

–4.6

3.73

AcQVDLF

60.4

28.2

–6.2

2.07

AcQADLF

78.6

36.7

–6.1

2.23

AcQGDLF

36.1

16.8

–6.5

1.76

AcQLALF

3.4

1.6

–7.9

0.37

AcQLGLF

10.4

4.9

–7.3

1.03

AcQLDVF

1215.0

567.0

–4.4

3.86

AcQLDAF

246.7

115.1

–5.4

2.91

AcQLDGF

1524.0

711.2

–4.3

3.99

AcQLDLL

20.96

9.8

–6.9

1.44

AcQLDLA

555.2

259.1

–4.9

3.39

AcQLDLG

1067.0

497.9

–4.5

3.78

Ac0

Kd (µM) ∆G (298K) (kcal/mol)

a

Peptide

Mutation

∆∆G

b

∆∆∆GA–G

Q1

L2

0.29

-0.46

D3

L4

F5

a

0.66

1.08

0.39

Binding energy difference compared to AcQLDLF. b Difference in binding energy upon replacing

alanine with glycine.
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The acetylated N-terminus (Ac0) of AcQLDLF mimics the main-chain of LMs by providing a
carbonyl oxygen to accept a H-bond (Figure 1A). Replacing Ac0 with a charged primary amine at the
N-terminus significantly decreased affinity (Table 1). Replacing Q1 with glutamate increased Kd
significantly but substitution with asparagine, which has a shorter side chain, led only to a modest
increase. Reducing Q1 down to alanine or glycine greatly reduced affinity and this change also
precluded correct positioning of the Ac0A1L2 sub-motif, as evidenced by the lack of electron density in
the map of the SCAcALDLF complex (Figure 1B). These findings establish the crucial importance of the
two H-bonds formed from the Q1 side-chain for binding in subsite II.
Replacing the hydrophobic residue L2 with valine, alanine or glycine had less effect on binding than
changes at Q1, while substituting D3 for alanine or glycine had almost no effect. Additionally, replacing
L2 or D3 with alanine did not alter the bound peptide conformations (Figure 1C and1D relative to 1A).
Substitution of L4 with valine had a strongly detrimental effect on binding, highlighting the strict
steric requirements for binding in this region of subsite 1. Replacing L4 with alanine significantly
reduced affinity as well as crystallographic ligand occupancy, as evidenced by the poor peptide
electron density in the SCAcQLDAF complex (Figure 1E). A glycine residue at this position further
reduced affinity. The significant difference in binding energy observed for the alanine-versus-glycine
substituted peptides at position 4 (∆∆∆G = 1.08 kcal/mol; Table 1) may be due to the higher flexibility
of glycine. This increased flexibility would impose a larger entropic cost upon binding and reduce the
likelihood of G4F5 binding in subsite I and triggering subsequent subsite II binding events (see
sequential binding model below).
Replacement of F5 with leucine produced a modest increase in Kd but, in cases with alanine or
glycine, there was detrimental effect on binding that was similar to the same substitutions at the L4
position. Interestingly, the SCAcQLDLA complex structure (Figure 1F) showed that replacement of F5
8
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with alanine causes this residue to be flipped out of subsite I leaving half of the subsite unoccupied.
This is consistent with a sub-motif (e.g. L4F5) needing to fully occupy subsite I before binding
interactions are triggered in subsite II (see sequential binding model below).
Entropy loss upon binding diminishes linear motif affinity for the E. coli SC. The alanine and
glycine scans above showed that these mutations significantly reduce binding affinity, with a higher
penalty observed for glycine (except at position L2). This can be explained by the reduced hydrophobic
interactions possible with glycine (vs. alanine) and because of the higher flexibility of glycine residues.
Since glycine can adopt a greater range of backbone phi/psi angles compared to alanine there is a
greater entropic cost associated with glycine-containing peptides.
Molecular dynamics (MD) simulations and molecular mechanics (MM) calculations with PoissonBoltzmann Surface Area (PBSA) solvation were performed to decompose the energy of LM peptides
binding to the SC and to quantify the contribution of ligand deformation entropy. The following
equation shows how the changes in Gibbs free energy (∆G) were decomposed:39
∆G = Gcomplex–Greceptor– Gligand
=EMM + Esolv +Edef – T∆S
=Evdw +Eelec + Epb + Ecavity +Edef – T∆S
Briefly, EMM represents the molecular mechanics (MM) interaction energy difference upon complex
formation, comprised of the van der Waals (VDW) interaction energy (Evdw) and electrostatic
interaction energy (Eelec). Esolv is the difference in solvation energy and is comprised of Epb and Ecavity.
Both EMM and Esolv were calculated for the complex using a single-trajectory approach.39 The ligand
energy difference upon binding (deformation energy, Edef) was calculated from a separate MD
simulation and MM/PBSA calculation on the free peptide alone (EFree), and the energy of the bound
9
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peptide (Ebound). Receptor deformation in the calculation of EMM and Esolv was ignored. Conformational
entropy (–T∆S) was calculated using the triple-trajectory approach with normal mode analysis.39
Table 2. MD simulation and MM-PBSA calculation data for peptides binding to the E. coli SC (units
in kcal/mol, details in Table S2).
EMM + Esolv Edef –T∆Sdef –T∆S

∆G

AcQLDLF

–49.6

1.4

6.5

20.8

–27.3

AcALDLF

–40.7

3.2

4.2

21.6

–15.8

AcQADLF

–45.9

–0.1

5.5

18.3

–27.7

AcQLALF

–47.3

–0.8

–1.1

22.5

–25.6

AcQLDAF

–44.4

0.4

4.8

20.2

–23.8

AcQLDLA

–45.7

2.0

4.2

23.6

–20.1

Although the calculations did not reproduce the experimentally determined binding free energies
(Table 2),36 they performed well in distinguishing the good from the poor binders amongst similar
peptides and in a pattern consistent with the FP data (Table 1). Ligand deformation energy (Edef) was
similar among the peptides relative to AcQLDLF. Ligand deformation entropy (–T∆Sdef) represents the
difference between the conformation entropy of bound and free peptide. In almost all cases, the
entropic cost of ligand deformation (–T∆Sdef) accounts for a significant portion of the unfavorable
conformational entropy loss (–T∆S) and thus the Gibbs energy (∆G).
Isothermal titration calorimetry (ITC) was used to provide corroborative evidence of ligand
deformation on entropy. Entropy differences (–T∆S) derived from the ITC measurements represent
global values, hence not identical to the corresponding term in the computational studies (Table 2).
Only strongly binding peptides were examined in these experiments as ligand solubility and receptor
10
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concentration placed limitations on the measurable binding constants. The ∆G values from the ITC
measurements (Table 3) were found to be consistent with the FP results (Table 1).
Table 3. Thermodynamic data for peptides binding to the E. coli SC as determined by ITC (at 298K,
units in kcal/mol).
∆H

–T∆S

∆G

AcQLDLF

–13.66

5.36

–8.30

Ac0

QLDLF

–6.39

0.35

–6.03

Q1

AcNLDLF

–7.40

1.83

–5.57

L2

AcQVDLF

–11.93

5.60

–6.33

AcQADLF

–13.60

7.21

–6.39

AcQGDLF

–14.66

8.05

–6.61

D3

AcQLALF

–12.18

3.73

–8.46

F5

AcQLDLL

–11.00

3.99

–7.01

The greatly reduced entropic cost of binding observed when Q1 was mutated to asparagine suggests
that the bound N1-containing peptide is poorly ordered. This correlates well with the poorly ordered
peptide structure observed in the SCAcALDLF crystal structure (Figure 1B). The peptide lacking the Ac0
group is probably also disordered when bound given its low binding entropic penalty. The entropic
costs of binding for peptides with mutations at positions L2, D3 and F5 were all similar to the reference
peptide, suggesting these would likely adopt similar peptide-binding poses to that observed in the
reference SCAcQLDLF structure. In the cases of D3 and F5 replacement, it is likely that reductions in
residue size and the resulting reductions in desolvation energy produced the net reductions in entropic
11
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cost of binding when compared to the reference AcQLDLF peptide.
Replacement of L2 with valine, alanine or glycine showed similar binding enthalpy with increased
entropic costs of binding compared with the reference peptide. This may be explained by the higher
flexibility (and hence conformational entropy) of unbound peptides containing smaller side chains at
position 2 resulting in increased entropy loss upon binding of these peptides to the SC. This supports
our hypothesis that differences in ligand deformation accounts for a significant part of the entropy of
binding. By comparison, F5 is a terminal residue and its contribution to overall vibrational freedom
(and hence conformational entropy) would be smaller.
An anchor-based sequential binding model for LM recognition by the E. coli SC. The impact of
A or G mutations at L4 on binding affinity, as measured by FP (Table 1), suggested a crucial role for
this residue in the binding process: the alanine mutant had reduced affinity due to reduced interaction,
while the glycine mutant impaired binding to a much greater extent. We propose that deformation
entropy of the ligand cannot fully account for the disproportionate effect of alanine to glycine
substitution at position L4 (and to a lesser extent D3) compared to other positions. This finding led us to
propose a sequential binding model whereby the L4F5 sub-motif establishes primary contacts with the
subsite I pocket, which is then followed by orientation and binding of the flanking residues of the
peptide in subsite II. According to this model, the entropic penalty of ligand deformation for glycine
mutations at the D3 or L4 positions would disfavor subsequent binding of the Ac0Q1L2 sub-motif. This
model can explain the impact of mutations on the kinetic constants of LM association and dissociation,
with surface plasmon resonance experiments having shown that such interactions are fast-on and fastoff,32 a feature that is commonly observed in LM binding.40 Given the rapid kinetics, we reasoned that
the dissociation phenomenon was amenable to steered molecular dynamics (SMD) simulations.
The early dissociation process of the Ac0Q1L2A3L4F5 mutant peptide from the SC was chosen for the
12
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simulation. The D3 to alanine mutant was used because of its small size and because D3 was shown to
make only a minor contribution to the binding energy. Three calculations were performed where
steering forces were applied to the mass centers of (1) the whole peptide, (2) the Ac0Q1L2 and (3) L4F5
sub-motifs (Figure 2). The Boltzmann-averaged cumulative work calculated after Jacobian correction41
suggested that the L4F5 sub-motif is more likely to dissociate from the complex first as it requires the
least work (i.e. shallowest slope in the trajectory). Additionally, the calculations showed that a lower
energy barrier lies along the L4F5 binding/dissociating pathway in comparison with the pathway in
which Ac0Q1L2 dissociates first (as indicated by reduced cumulative work).

Figure 2. Plot of cumulative work vs. distance during SMD simulated dissociation of AcQLALF from the SC. Steering
forces were applied to the three different centers of mass indicated.

Binding of the dipeptides AcQL, AcLF (and their various C/N-terminal variants) to the SC was next
assessed by FP assay and X-ray crystallography to test the hypothesis that the L4F5 sub-motif must
bind/unbind first. AcQL and its analogues failed to show any binding to the clamp by either method
(Table S3). In contrast, AcLF and its analogue 4MF ((S)-2-(4-methylpentanamido)-3-phenylpropanoic
acid) showed weak affinity (IC50=1.1 and 4.44 mM respectively, Table S3) and both were shown to
occupy subsite I in their respective X-ray structures, SCAcLF and SC4MF (Figure 3A–C, crystallographic
data in Table S4). AcQL and its C-terminal variants failed to demonstrate binding by X-ray
crystallography even when AcLF was pre-bound into subsite I (crystallographic data not shown).
13
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The SC4MF complex structure, determined in space group (P1), showed that binding of 4MF causes a
minor perturbation of the binding pocket at S346 and H175 (Figure 3A) when compared with an apoSC structure determined in the same space group (SCP1, crystallographic data in Table S4). A gating
residue M362 retains a "closed" conformation (Chi2 angle –177°) in both of these structures, which
blocks the passageway between subsites I and II (Figure 3A).
The structure of the SCAcLF complex, determined in space group P21, showed that binding of
dipeptide AcLF to chain B of the SC (Figure 3B) causes no apparent changes in the binding site, as
compared with the apo-clamp structure determined in the same space group (PDB entry 1MMI, Figure
3B). In both of these structures, the M362 gating residue retains the “closed” conformation. However,
when the same dipeptide bound to chain A (Figure 3C) the binding features observed were similar to
those seen with longer peptides (e.g. AcQLDLF and DNA Pol IV little finger domain, Figure 3D),
including movements in the side-chains of M362 and S364. The binding observed in chain B appears to
be due to stabilization by a nearby symmetry-related molecule (Figure S2) and may represent a preequilibrium state, with equilibrium binding guided by desolvation and formation of a H-bond between
the L4 amide and G174 carbonyl groups. The gating residue M362 is unmoved in chain B (Chi2 angle –
170°) but is in a "half-open" conformation (Chi2 angle –74° and -93° for alternate conformers) in chain
A, exposing the G174 carbonyl group as a H-bond acceptor.
The SCAcLF and SC4MF crystal structures suggest that the L4F5 sub-motif acts as an anchor capable of
binding on its own. We propose that the SC4MF, SCAcLF and SCAcQLALF complex structures exemplify
snapshots along the pathway to binding. The compound 4MF bound in subsite I highlights the initial
contact, while AcLF makes an additional H-bond with G174 and subsequently triggers partial opening
of the M362 gate. AcQLALF occupies subsite I and subsite II with the M362 in the fully "open"
conformation (Chi2 55°, Figure 3D). The SMD simulation of AcQLALF dissociation (Figure 2)
demonstrated that “pulling” the anchor sub-motif (L4F5) reduces the energetic barrier for dissociation
14
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of the rest of the peptide.

A

B

C

D

Figure 3. Crystal structures of SC4MF (A), and SCAcLF chain B (B) and SCAcLF chain A (C). SC residues are presented in
white with non-carbon atoms CPK colored. Structures of the equivalent native SC structures with equivalent crystal packing
are superimposed and shown in yellow (SCP1 onto SC4MF, 1MMI chain B and A onto SCAcLF chain B and A, respectively).
The peptide atoms are CPK colored. Dashed lines in red represent H-bonds. Electron density maps (mFo–DFc) contoured at
3σ are shown in green wire-basket form. (D) The crystal structure of the SC/Pol IV little finger domain (PDB entry 1UNN)
is shown superimposed onto SCAcQLALF. The DNA Pol IV little finger domain is shown in pink. The enlarged view of the
binding pocket in the SCAcQLALF structure shows the SC pocket (white), the AcQLALF peptide (grey). Non-carbon atoms
are CPK colored. Dashed lines in red represent H-bonds. A bridging water molecule (W0) is shown as a red sphere.
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In summary, the model proposes that the binding (or unbinding) of the L4F5 anchor sub-motif triggers
subsequent binding (or unbinding) of the Ac0Q1L2 sub-motif. Acting together, these two sub-motifs
contribute most of the binding energy of the consensus motif, as evidenced by the FP data. Since the
binding of the consensus motif to the SC determines the binding of the entire protein,31, 33 the binding
of the consensus motif should precede the binding of the rest of protein. For instance, in the case of the
"little finger" domain of DNA Pol IV (PDB entry 1UUN, Figure 3D), the terminal residues equivalent
to the consensus motif should initiate both binding and unbinding.
Almost-buried polar atoms (ABPAs) present a kinetic barrier. The mutational analysis of
consensus peptide binding suggested equal importance for the L4F5 and Ac0Q1 motifs to affinity, with
the L4F5 sub-motif functioning as an anchor to initiate binding. Initially we thought that the "closed"
conformation of M362 was acting as a gate blocking binding at subsite II. However, MD simulations of
the native SC monomer showed that the M362 Chi2 angles corresponding to the open/closed
conformations are equally populated in the trajectory (Figure S3), suggesting that the conformation of
M362 is probably not determining the order of binding.
We instead propose that a kinetic barrier, caused by differences in the nature of desolvation and
resolvation of subsites I and II, is responsible for L4F5 acting as the anchor sub-motif. Subsite I consists
mostly of hydrophobic residues that contact the side-chains of L4F5 (Figure 4A). In contrast, subsite II
makes multiple H-bonds with the Ac0Q1L2 sub-motif (Figure 4B), including some mediated by the
bridging water (W0). The trajectory of a 5 ns native SC simulation, which included all crystallographic
water molecules, showed that W0 remained bound (Figure S4) and was tightly restrained by H-bonds to
M362O and N320N (Figure S5). It was therefore concluded that W0is a structural water molecule in the
SC.
A recent study showed that H-bond interactions between the protein and ligands that are shielded
16
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from bulk solvent contribute to slow binding/unbinding kinetics.37 This was explained by the
desolvation and resolvation of “almost-buried polar atoms” (ABPAs) upon ligand binding/unbinding,
which involves a transition state that is energetically unfavorable because it occurs asynchronously
with dehydration/rehydration.37 ABPA refers to atoms with < 10 Å2 solvent accessible surface area
(SASA) located within a concave site where the ∆SASA is < 0 (change of SASA with increased probe
radius). For the E. coli SC, W0 and M362O are ABPA atoms according to this definition while all other
polar atoms making H-bonds in both subsites I and II are non-ABPAs (Table S5).
To determine the role of W0 and M362O as ABPAs along the proposed dissociation pathway, we
performed SMD simulations of a model AcQL dipeptide dissociating from subsite II, using initial
coordinates from the SCAcQLALF complex structure. For comparison, a SMD simulation was carried out
for dissociation of AcLF from subsite I, using coordinates from the SCAcLF complex as the starting
structure. The AcLF dipeptide makes one H-bond with a G174O, a non-ABPA. Jacobian corrections
were applied in the cumulative work calculations.41
The cumulative work plot for AcLF dissociation is uniformly ascending showing only one energetic
minimum (Figure 4C). As a non-ABAP, the G174O in subsite I is solvent accessible even when AcLF
is bound (Figure 4G). The breaking of the H-bond with the dissociating AcLF (Figure 4E) is offset by
increasing contacts with bulk solvent (Figure 4G), thus no kinetic barrier is observed in the case of
AcLF dissociation (Figure 4C).
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Figure 4. (A, B) Model structures for SMD simulation of AcLF and AcQL dissociation from subsites I and II, respectively.
The dipeptides are colored grey and the binding pockets white. Non-carbon atoms are CPK colored. Dashed lines represent
H-bonds. A bridging water (W0) is shown as a red sphere. (C, D) Boltzmann averaged cumulative work of the dipeptides
pulled for 5 Å from the mass center of the pockets. (E, F) Distances of H-bond pair atoms presented as a Boltzmann
average of 20 simulation trajectories. (G, H) Number of water contacts (<3.4 Å) Boltzmann averaged with 20 simulation
trajectories.
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The cumulative work of steered dissociation of the model AcQL began with a steep ascending
curve that quickly flattened (Figure 4D). This represents the peak of an energy barrier where the
system could dissociate or re-associate. Dissociation was accompanied by the breakage of the Hbond between the W0 and the Q1 side-chain (Figure 4F) and reformation of H-bonds with the
solvent (i.e. first layer resolvation) (Figure 4H). Breakage of the H-bond between M362O and
the Q1 side-chain preceded breakage of the W0 to Q1 H-bond (Figure 4F), while resolvation of
M362O was insignificant (Figure 4H). At a distance of 1.5 Å, abrupt dissociation of the W0 to Q1
H-bond occurs, leading to greater movement of the Q1 side-chain (Figure 4F) and formation of
the first solvent layer in subsite II. Prior to this event, W0 is completely shielded from bulk
solvent. Thus, there was a transient state (distance <1.5 Å) where the system increases in energy
as the H-bond with W0 is broken with no compensatory formation of H-bonds with the first
solvation layer.
We propose that the desolvation and resolvation of the structural water W0 as an ABPA
represents the kinetic barrier on the pathway of ligand dissociation and association and thus have
an impact on the ligand affinity. Conversely, binding of AcLF to the SC is not opposed by this
barrier as it is not present in subsite I. A similar kinetic barrier was observed in the work plot for
the SMD simulation of the SCAcQLALF complex structure steered at the Ac0Q1L2 sub-motif
(Figure 2).
CONCLUSION
This study has identified two critical subsite-specific interactions: (1) the non-polar contacts of
the L4F5 sub-motif with subsite I, and (2) the H-bond network of the Q1 residue with subsite II
mediated by a structurally conserved water molecule. We propose that the L4F5 sub-motif
establishes primary contact with subsite I and that binding is entropically favorable due to
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desolvation of the hydrophobic L4F5 sub-motif and binding site. Anchoring of the L4F5 sub-motif
assists the Q1 side-chain in overcoming the kinetic barrier caused by formation of H-bonds with
the conserved water as an ABPA of subsite II. The H-bond network formed upon positioning of
Q1 in subsite II stabilizes the complex as the kinetic barrier similarly opposes association and
dissociation. Dissociation occurs in the same order with the L4F5 sub-motif dissociating first.
This sequential binding model for ligand recognition by the E. coli SC could inform design
strategies for small-molecule inhibitors as probes or drugs, if the critical interactions are to be
reproduced.
To date, inhibition of LM recognition for therapeutic purposes has yielded few successes.
Despite the similarities, LM recognition may differ in the composition of the anchor motif (e.g.
phosphoserine/threonine-containing anchor motif recognized by SH2/WW domains,42 PxxP
binding to SH3 domain43) and potential structural transformation (folding-coupled binding in the
case of P53 binding to MDM244). These factors complicate any effort to completely elucidate the
binding process. The LM recognition by the E. coli SC is a relatively simple case where the
binding has no allosteric consequences, allowing the effect of the sub-motifs to be partitioned.
The sequential binding model with differential solvation as a key driver revealed here may also
apply to evolutionarily related and/or biochemically similar systems, such as the PCNAmediated interactions in eukaryotic DNA replication via recognition of a -Qxx[I/L]xxFF motif.24
Taking into account those structural and kinetic factors will assist drug design efforts targeting
these systems.
Materials and Methods
Protein over-expression, purification and crystallization. The protein production and
purification followed the published protocol.45 Crystals were grown at 285 K by the hanging-
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drop vapor diffusion method. The hanging drop was composed of 1 µl of SC (53 mg/ml) mixed
with the same volume of a reservoir solution composed of 100 mM MES pH 6.5, 100-150 mM
CaCl2 and 25-30%(v/v) PEG400.The reservoir volume was 1 ml. Ligands were soaked into the
crystal at 2-5 mM with <10 % DMSO.
X-ray data collection. All crystals were mounted onto MiTeGen™ loops on pins with
magnetic caps. For in-house data collection, crystals were flash-frozen to 100 K using an Oxford
Cryo-stream. Diffraction data were collected using a MAR345 desktop beamline using CuKα Xray from a Rigaku 007HF rotating anode generator with Varimax™ optics.
For synchrotron data collection, the SSRL Automated Mounting system (SAM) was used.
Mounted crystals were flash-frozen in liquid nitrogen and placed in the SAM cassettes.
Diffraction data were collected at the Australian Synchrotron, Beamline MX1 using X-rays of
wavelength 0.95 Å.
Data processing, structural solution and refinement. Crystal data sets were integrated,
merged and scaled with either HKL200046 or MOSFLM and SCALA of the CCP4 software
package.47 The structures were solved by molecular replacement with CCP4 using the Protein
Data Bank entry 1MMI as a starting model. Iterative model building and refinement was done
with Refmac548 and Coot49.
Fluorescence polarization assay. All FP experiments were conducted with a POLARstar
Omega plate reader using non-treated black sterile 96-well plates (Greiner, USA). The buffer
contains 10 mM HEPES (pH 7.4), 1mM EDTA, 1 mM DTT, 0.07% Nonidet P-40 and 5%
DMSO. Various fluorescently-labeled peptides were designed and tested. One fluorescent
peptide, 5’-Fluorescein(FAM)-QLDLF-OH (GL Biochem, China) with >95% purity confirmed
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by HPLC-MS, was used for the competition assay with 10 nM of tracer and 50 nM of the SC
monomer. Blank control (buffer), negative control (buffer and the peptide) and positive control
(buffer, peptide and the SC) were used for data standardization to yield the extent of inhibition.
Experiments were carried out in duplicate. Curves were fitted using GraphPad Prism v5.01
(GraphPad Software, USA). Binding-saturation curve fitting was applied to tracer binding. Doseresponse curve fitting was applied to competition assays with variable slope, constraining Top at
100 and Bottom at 0.
Isothermal Titration Calorimetry. ITC was performed using a MicroCal Auto-iTC200
calorimeter (Microcal, GE Healthcare) at 298 K. The SC was dialyzed against a buffer (10 mM
HEPES pH 7.2, 0.15 M NaCl and 1 mM EDTA) and the same buffer was used to dissolve the
peptides. The feedback mode was "high" with the reference power setting of 10 µcals-1. The cell
was stirred at 1000 rpm and the thermostat at 25 °C. Experiments were conducted with 19
injections of 2 µL in 4s with 200s spacing. The first injection of 0.4 µl was discarded in all cases.
Peptides of 2-5 mM were titrated in sequential injections (2 µl each) into 54 or 90 µM SC
monomer. Data were corrected for control experiments with peptide titrated into buffer only.
Data analysis was carried out with Origin 7.0 using one-site binding data fitting.
Molecular dynamics simulation, molecular mechanics calculation and Steered molecular
dynamics simulation. MD/SMD simulations were carried out with the AMBER 11 software
package39 and the procedures followed the published methods.37 Details are included in the
supporting information.
ASSOCIATED CONTENT

22

Page 23 of 30

Supporting Information. Crystallographic data, ITC data, tested dipeptides, additional
computational data and figures, detailed materials and methods. This material is available free of
charge via the Internet at http://pubs.acs.org.
Accession Codes. The atomic coordinates and structure factors for SCAcALDLF, SCAcQADLF,
SCAcQLALF, SCAcQLDAF, SCAcQLDLA, SCAcLF, SC4MF, and SCP1 have been deposited with the protein
data bank under accession codes 4K3M, 4K3O, 4K3P, 4K3Q, 4K3R, 4K3L, 4K3K and 4K3S,
respectively.
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ABBREVIATIONS
SC, sliding clamp; LM, linear motif; Ac, acetyl group; PCNA: proliferating cell nuclear antigen;
SMD, steered molecular dynamics simulation; ABPA, almost buried polar atoms; FP,
fluorescence polarization; MD, molecular dynamics simulation; MM, molecular mechanics;
PBSA, Poisson Boltzmann surface area; PDB, protein data bank; SASA, solvent accessible
surface area; SPR, surface plasmon resonance; ITC, isothermal titration calorimetry; IC50, half-
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maximum inhibitory concentration; SH2, Src homology 2; SH3, Src homology 3; MDM2,
Mouse double minute 2 homolog.
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